Wednesday, May 04, 2016 12:50:51 PM
GREAT NEWS FOR CBIS!!!!MUST READ ARTICLE BELOW...........
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial ...
Yahoo Finance? - 2 hours ago
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
.
Marketwired
Cannabis Science, Inc.
2 hours ago
?
?
?
?
. ?
?
?
.
..
.
.
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science believes this is it and the Company is very well positioned to move into mass expansion mode as new projects and current drug development initiatives get underway and move forward with exponential growth and sharply increased value.
Fortune Story on MAPS PTSD Study approved by the DEA:
The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American military veterans, a spokesperson for the government agency confirmed to Fortune. While other trials have studied the medical benefits of marijuana and cannabis extracts like cannabidiol, this is the first time regulators have allowed testing of the marijuana plant itself for the purpose of developing it into a legal medical drug.
The Multidisciplinary Association for Psychedelic Studies (MAPS), an organization researching legal uses for marijuana and other mind-altering drugs, is conducting the trial, which is funded by a $2.2 million grant from Colorado's state health department. MAPS had worked for more than five years to obtain clearance from regulators to use pot in the trial; while it received the OK from the U.S. Food and Drug Administration in 2011 and from the U.S. Public Health Service in 2014, it still had to wait for the DEA's approval in order to proceed.
http://fortune.com/2016/04/22/dea-medical-marijuana/?iid=sr-link1
Harborside story from the SFGATE:
.
.
Related Quotes
.
CBIS
0.0176
+21.38%
Cannabis Science, Inc.? Watchlist
0.0176+0.0031(21.38%)
OTC Markets11:34AM EST
GWPH Momentum Passed Around to Other Pot Stocks
TheStreet q 1 mth 20 days ago
More
.
In a milestone victory for the cannabis industry, the federal government agreed to drop its four-year bid to shut down Oakland's Harborside Health Center, the biggest medical marijuana dispensary in the country with more than 100,000 patients, city leaders said Tuesday.
The Department of Justice did not immediately comment on the deal, which Harborside said still needed to be finalized, with all of the parties in the legal fight signing off.
But Oakland officials joined the pot dispensary in an exultant news conference at City Hall, heralding a move they saw as symbolic of a federal withdrawal in the battle against an industry that is steadily marching toward acceptance -- and is viewed in Oakland not as a scourge but an economic engine.
"We celebrate the release from federal prosecution," said Mayor Libby Schaaf. "We believe in compassion, we believe in health."
http://www.sfgate.com/bayarea/article/Feds-drop-bid-to-shut-down-Harborside-in-big-win-7390365.php
The DEA has recently become more open to the benefits and plausibility of medical marijuana as a treatment option. In addition to green lighting this new trial, Harborside resolution, and of course with the agency recently announcing their intention to review the scheduling of marijuana as a drug within the first half of 2016. This is a great sign of progress for the agency.
"Can this be it? Will we see it sooner than later? We are so excited to be part of this industry as the federal government is starting to review antiquated policies, which have long acted as roadblocks to people seeking natural treatment options and Companies moving forward with viable treatment options for the people. I believe this is it. We are ready with all our formulations in place and new complex underway; we are certainly ready to rise to the occasion!" said Cannabis Science, Inc. CEO Raymond C. Dabney.
As federal and state policies loosen, companies like Cannabis Science will be able to perform studies, conduct trials, and roll out products much faster and more affordably. This progress is critical for companies to continue bringing more effective and affordable, natural treatments to patients across the country.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Contact:
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832 FREE
Cannabis Science, Inc.
Mr. Raymond C. Dabney
Director, President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832 FREE
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832 FREE
..
.
.
Rates
.
. .
.
.
?
View Comments (0) .
Share this
?
?
?
?
..
Recommended for You
Frontier, Time Warner Cable to discuss Dodger channel distribution
Frontier Communications executives have agreed to meet with Time Warner Cable representatives to discuss the stalemate over carriage of SportsNet LA, the TV channel owned by the Los Angeles Dodgers -- ...
Los Angeles Times
TWC $212.98 0.10%
More like this
Remove
Motley Fool Issues Rare "Double Down" Stock Alert
Past "double downs" have averaged remarkable 598% returns...
The Motley FoolSponsored
Student Loan Debt Haunts Parents After Son's Death
A new legislative proposal wants to eliminate taxes on forgiven student loan debt.
Credit.com
More like this
Remove
Microsoft Surface Pro 4: The smart person's guide
A powerful notebook/tablet hybrid like the Microsoft Surface Pro 4 can be a real advantage for many users. This guide describes its specs, who it's designed for, and why it matters.
TechRepublic
MSFT $50.00 0.44%
More like this
Remove
Play
Apple CEO Tim Cook appeared on Jim Cramer's TV show to tell investors they got it all wrong
Apple reported its first quarterly sales drop since 2003 last week, and its stock...
Business Insider
AAPL $94.25 -0.98%
More like this
Remove
Forget Social Security if you Own a Home (Do This)
If you own a home, you should read this. Thousands of homeowners did this yesterday, and banks are furious! Do this now before it's too late!
GetMyRefinanceSponsored
Target faces backlash on stance on transgender bathrooms
NEW YORK (AP) — Consumer backlash is growing against Target's stance on what type of bathrooms its transgender customers and employees can use.
Associated Press
TGT $79.90 -0.11%
More like this
Remove
What's Up at GW Pharmaceuticals (GWPH) in Q2 Earnings?
GW Pharmaceuticals (GWPH), which is set to report second-quarter fiscal 2016 results on May 5, had posted a positive surprise of 34.78%.
Zacks
More like this
Remove
This High-Yielding MLP Is a No-Brainer With Climbing Energy Prices
This offshore drilling master limited partnership generates a fat dividend yield of 12.27% and may be on track for capital appreciation.
TheStreet.com
RIG $10.14 -2.78%
More like this
Remove
Americans Urged To Do This Quick Computer Checkup
Don't buy a new PC or call a repair company before reading this. Simple "3 click Fix" will have your computer running like new again.
SpeedFixToolSponsored
Play
Jim Cramer: Happy to be be in what 'feels like an Apple c...
CNBC's Jim Cramer provides perspective on Apple's business strategy, and where the stock goes from here.
CNBC Videos
More like this
Remove
Why Under Armour's Founder Couldn't Care Less if Sports Authority Vanishes
Under Armour has other things going for it besides selling apparel to bankrupt Sports Authority.
TheStreet.com
UA $40.06 -6.25%
More like this
Remove
Charts show gold going to $1,340 and fast. Here's the signs to watch for
There are three key features to look out for in this breakout in the gold price, which also happens to confirm our analysis back in February.
CNBC
More like this
Remove
1 Fruit That "Fights" Diabetes
The diabetes industry hates this. This one fruit can help reduce blood sugar levels. If you're diabetic or pre-diabetic try this now.
Diabetes DestroyerSponsored
Million-dollar home market slumps
The luxury home market may be losing some of its luster, with homes selling for $1 million or more marking their biggest decline in more than two years.
CNBC
More like this
Remove
Critics question mine exploration near Alaska eagle preserve
ANCHORAGE, Alaska (AP) — In early winter, after most tourists have fled Alaska, another kind of visitor flies in: bald eagles, up to 4,000 of them.
Associated Press
More like this
Remove
10 Financial Decisions You'll Regret Forever
According to John Sweeney, executive vice president for retirement and investment strategies at Fidelity Investments, you're likely to reduce or suspend new contributions during the period you're repaying the loan. Keep in mind, too, that you'll be paying the interest on that 401(k) loan with…
Kiplinger
More like this
Remove
Seniors: Pay 0% credit card interest until 2018
Save hundreds today. Compare for free 0% intro APR for 21 months, free balance transfers, 5% cash back, $300 sign up bonuses and more.
CompareCards.comSponsored
Play
What's happening with Royal Dutch Shell?
Jason Gammel, equities analyst at Jefferies, discusses Royal Dutch Shell, its acquisition of BG and how it is responding to oil prices.
CNBC Videos
RDS-A $50.50 -1.93%
More like this
Remove
5 Oil Stocks with High Paying Dividends
Zacks
More like this
Remove
Is a Surprise Coming for Linn Energy (LINE) This Earnings Season?
Linn Energy (LINE) looks poised to beat analyst estimates this earnings season, with a favourable Zacks Rank and an ESP in positive territory.
Zacks
More like this
Remove
What Was Found In These Abandoned Airplanes Is...
Abandoned Airplanes Photos That Will Make Your Jaw Drop!
DefinitionSponsored
Coal's demise threatens Appalachian miners, firms as production moves West
Rock-bottom natural gas prices, regulations and China are battering U.S. coal.
USA TODAY
ANR $0.26 0.00%
More like this
Remove
How to Get a Perfect 850 FICO Credit Score Automatically
These days the web is full of stories about how to massage your credit history and score to look your best to lenders. On this site and others, you’ve probably seen stories like “ 7 Fast Ways to Raise ...
Money Talks News
More like this
Remove
Geron (GERN) Q1 Earnings: What's in Store for the Stock?
Investor focus will remain on pipeline updates from Geron (GERN).
Zacks
GERN $2.77 -2.46%
More like this
Remove
Free Tools! Get 'em before they're gone!
"Free" as in "Free" - We even cover the shipping! Visit this site to sign up for free samples in the mail. No credit card or purchase necessary.
Get it FreeSponsored
Edison International (EIX) Lags Q1 Earnings and Revenues
Edison International (EIX) reported first-quarter 2016 results, wherein adjusted earnings of 82 cents per share came in below of the Zacks Consensus Estimate of 89 cents by 7.9%.
Zacks
EIX $73.04 1.91%
More like this
Remove
Load more stories
What to read next
Official: Self-driving cars could lead to people having sex behind the …
Motley Fool Issues Rare "Double Down" Stock Alert
Sponsored The Motley Fool
?
Spanx Founder: My phone rang and he said, 'Sara? It's Warren Buffett.'
Railroad Exec: 'We still see a lot of headwinds'
This weak U.S. dollar is actually helping Janet Yellen
Shark Tank Star's Brilliant Advice On Mortgage
Sponsored The Easy Loan Site
?
Dairy Queen CEO: What it's really like to work for Warren Buffett
Get ready for 'reverse quantitative easing'
John Kasich Reported to Suspend Presidential Campaign
If You Plan to Retire or Are Retired Read This Now
Sponsored Agora Financial
?
Are the Good Times Over for Tech Stocks?
European Stocks Register Fourth-Straight Decline
What Was Found In These Abandoned Airplanes Is...
Sponsored Definition
?
Vicente Fox on Trump, Corruption, and Mexico's Economy
Shell's BG Risk Pays Off in First-Quarter Profit Surprise
Rich GOP donors blow another $63 million
Trump Makes Another Enemy. Homeowners are Excited!
Sponsored TheEasyLoanSite.com
?
Trump is ‘unhinged’ but don't discount him: Rendell
There’s only one fundamental driving the markets right now
Bill Gross: 'Helicopter money' is coming in a year or so
See What A Billion Dollar Home Looks Like
Sponsored Housely.com
?
How a 13-year-old got connected with Warren Buffett and Rory McIlroy
U.S. factory orders rise solidly; inventories pick up
.
.
Copyright © 2016 <a href=http://www.marketwired.com/>Marketwire</a> L.P. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
Data Disclaimer
Help / Suggestions
Privacy
About Our Ads
Terms
..
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial ...
Yahoo Finance? - 2 hours ago
Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
.
Marketwired
Cannabis Science, Inc.
2 hours ago
?
?
?
?
. ?
?
?
.
..
.
.
COLORADO SPRINGS, CO--(Marketwired - May 4, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science believes this is it and the Company is very well positioned to move into mass expansion mode as new projects and current drug development initiatives get underway and move forward with exponential growth and sharply increased value.
Fortune Story on MAPS PTSD Study approved by the DEA:
The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American military veterans, a spokesperson for the government agency confirmed to Fortune. While other trials have studied the medical benefits of marijuana and cannabis extracts like cannabidiol, this is the first time regulators have allowed testing of the marijuana plant itself for the purpose of developing it into a legal medical drug.
The Multidisciplinary Association for Psychedelic Studies (MAPS), an organization researching legal uses for marijuana and other mind-altering drugs, is conducting the trial, which is funded by a $2.2 million grant from Colorado's state health department. MAPS had worked for more than five years to obtain clearance from regulators to use pot in the trial; while it received the OK from the U.S. Food and Drug Administration in 2011 and from the U.S. Public Health Service in 2014, it still had to wait for the DEA's approval in order to proceed.
http://fortune.com/2016/04/22/dea-medical-marijuana/?iid=sr-link1
Harborside story from the SFGATE:
.
.
Related Quotes
.
CBIS
0.0176
+21.38%
Cannabis Science, Inc.? Watchlist
0.0176+0.0031(21.38%)
OTC Markets11:34AM EST
GWPH Momentum Passed Around to Other Pot Stocks
TheStreet q 1 mth 20 days ago
More
.
In a milestone victory for the cannabis industry, the federal government agreed to drop its four-year bid to shut down Oakland's Harborside Health Center, the biggest medical marijuana dispensary in the country with more than 100,000 patients, city leaders said Tuesday.
The Department of Justice did not immediately comment on the deal, which Harborside said still needed to be finalized, with all of the parties in the legal fight signing off.
But Oakland officials joined the pot dispensary in an exultant news conference at City Hall, heralding a move they saw as symbolic of a federal withdrawal in the battle against an industry that is steadily marching toward acceptance -- and is viewed in Oakland not as a scourge but an economic engine.
"We celebrate the release from federal prosecution," said Mayor Libby Schaaf. "We believe in compassion, we believe in health."
http://www.sfgate.com/bayarea/article/Feds-drop-bid-to-shut-down-Harborside-in-big-win-7390365.php
The DEA has recently become more open to the benefits and plausibility of medical marijuana as a treatment option. In addition to green lighting this new trial, Harborside resolution, and of course with the agency recently announcing their intention to review the scheduling of marijuana as a drug within the first half of 2016. This is a great sign of progress for the agency.
"Can this be it? Will we see it sooner than later? We are so excited to be part of this industry as the federal government is starting to review antiquated policies, which have long acted as roadblocks to people seeking natural treatment options and Companies moving forward with viable treatment options for the people. I believe this is it. We are ready with all our formulations in place and new complex underway; we are certainly ready to rise to the occasion!" said Cannabis Science, Inc. CEO Raymond C. Dabney.
As federal and state policies loosen, companies like Cannabis Science will be able to perform studies, conduct trials, and roll out products much faster and more affordably. This progress is critical for companies to continue bringing more effective and affordable, natural treatments to patients across the country.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Contact:
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832 FREE
Cannabis Science, Inc.
Mr. Raymond C. Dabney
Director, President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832 FREE
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832 FREE
..
.
.
Rates
.
. .
.
.
?
View Comments (0) .
Share this
?
?
?
?
..
Recommended for You
Frontier, Time Warner Cable to discuss Dodger channel distribution
Frontier Communications executives have agreed to meet with Time Warner Cable representatives to discuss the stalemate over carriage of SportsNet LA, the TV channel owned by the Los Angeles Dodgers -- ...
Los Angeles Times
TWC $212.98 0.10%
More like this
Remove
Motley Fool Issues Rare "Double Down" Stock Alert
Past "double downs" have averaged remarkable 598% returns...
The Motley FoolSponsored
Student Loan Debt Haunts Parents After Son's Death
A new legislative proposal wants to eliminate taxes on forgiven student loan debt.
Credit.com
More like this
Remove
Microsoft Surface Pro 4: The smart person's guide
A powerful notebook/tablet hybrid like the Microsoft Surface Pro 4 can be a real advantage for many users. This guide describes its specs, who it's designed for, and why it matters.
TechRepublic
MSFT $50.00 0.44%
More like this
Remove
Play
Apple CEO Tim Cook appeared on Jim Cramer's TV show to tell investors they got it all wrong
Apple reported its first quarterly sales drop since 2003 last week, and its stock...
Business Insider
AAPL $94.25 -0.98%
More like this
Remove
Forget Social Security if you Own a Home (Do This)
If you own a home, you should read this. Thousands of homeowners did this yesterday, and banks are furious! Do this now before it's too late!
GetMyRefinanceSponsored
Target faces backlash on stance on transgender bathrooms
NEW YORK (AP) — Consumer backlash is growing against Target's stance on what type of bathrooms its transgender customers and employees can use.
Associated Press
TGT $79.90 -0.11%
More like this
Remove
What's Up at GW Pharmaceuticals (GWPH) in Q2 Earnings?
GW Pharmaceuticals (GWPH), which is set to report second-quarter fiscal 2016 results on May 5, had posted a positive surprise of 34.78%.
Zacks
More like this
Remove
This High-Yielding MLP Is a No-Brainer With Climbing Energy Prices
This offshore drilling master limited partnership generates a fat dividend yield of 12.27% and may be on track for capital appreciation.
TheStreet.com
RIG $10.14 -2.78%
More like this
Remove
Americans Urged To Do This Quick Computer Checkup
Don't buy a new PC or call a repair company before reading this. Simple "3 click Fix" will have your computer running like new again.
SpeedFixToolSponsored
Play
Jim Cramer: Happy to be be in what 'feels like an Apple c...
CNBC's Jim Cramer provides perspective on Apple's business strategy, and where the stock goes from here.
CNBC Videos
More like this
Remove
Why Under Armour's Founder Couldn't Care Less if Sports Authority Vanishes
Under Armour has other things going for it besides selling apparel to bankrupt Sports Authority.
TheStreet.com
UA $40.06 -6.25%
More like this
Remove
Charts show gold going to $1,340 and fast. Here's the signs to watch for
There are three key features to look out for in this breakout in the gold price, which also happens to confirm our analysis back in February.
CNBC
More like this
Remove
1 Fruit That "Fights" Diabetes
The diabetes industry hates this. This one fruit can help reduce blood sugar levels. If you're diabetic or pre-diabetic try this now.
Diabetes DestroyerSponsored
Million-dollar home market slumps
The luxury home market may be losing some of its luster, with homes selling for $1 million or more marking their biggest decline in more than two years.
CNBC
More like this
Remove
Critics question mine exploration near Alaska eagle preserve
ANCHORAGE, Alaska (AP) — In early winter, after most tourists have fled Alaska, another kind of visitor flies in: bald eagles, up to 4,000 of them.
Associated Press
More like this
Remove
10 Financial Decisions You'll Regret Forever
According to John Sweeney, executive vice president for retirement and investment strategies at Fidelity Investments, you're likely to reduce or suspend new contributions during the period you're repaying the loan. Keep in mind, too, that you'll be paying the interest on that 401(k) loan with…
Kiplinger
More like this
Remove
Seniors: Pay 0% credit card interest until 2018
Save hundreds today. Compare for free 0% intro APR for 21 months, free balance transfers, 5% cash back, $300 sign up bonuses and more.
CompareCards.comSponsored
Play
What's happening with Royal Dutch Shell?
Jason Gammel, equities analyst at Jefferies, discusses Royal Dutch Shell, its acquisition of BG and how it is responding to oil prices.
CNBC Videos
RDS-A $50.50 -1.93%
More like this
Remove
5 Oil Stocks with High Paying Dividends
Zacks
More like this
Remove
Is a Surprise Coming for Linn Energy (LINE) This Earnings Season?
Linn Energy (LINE) looks poised to beat analyst estimates this earnings season, with a favourable Zacks Rank and an ESP in positive territory.
Zacks
More like this
Remove
What Was Found In These Abandoned Airplanes Is...
Abandoned Airplanes Photos That Will Make Your Jaw Drop!
DefinitionSponsored
Coal's demise threatens Appalachian miners, firms as production moves West
Rock-bottom natural gas prices, regulations and China are battering U.S. coal.
USA TODAY
ANR $0.26 0.00%
More like this
Remove
How to Get a Perfect 850 FICO Credit Score Automatically
These days the web is full of stories about how to massage your credit history and score to look your best to lenders. On this site and others, you’ve probably seen stories like “ 7 Fast Ways to Raise ...
Money Talks News
More like this
Remove
Geron (GERN) Q1 Earnings: What's in Store for the Stock?
Investor focus will remain on pipeline updates from Geron (GERN).
Zacks
GERN $2.77 -2.46%
More like this
Remove
Free Tools! Get 'em before they're gone!
"Free" as in "Free" - We even cover the shipping! Visit this site to sign up for free samples in the mail. No credit card or purchase necessary.
Get it FreeSponsored
Edison International (EIX) Lags Q1 Earnings and Revenues
Edison International (EIX) reported first-quarter 2016 results, wherein adjusted earnings of 82 cents per share came in below of the Zacks Consensus Estimate of 89 cents by 7.9%.
Zacks
EIX $73.04 1.91%
More like this
Remove
Load more stories
What to read next
Official: Self-driving cars could lead to people having sex behind the …
Motley Fool Issues Rare "Double Down" Stock Alert
Sponsored The Motley Fool
?
Spanx Founder: My phone rang and he said, 'Sara? It's Warren Buffett.'
Railroad Exec: 'We still see a lot of headwinds'
This weak U.S. dollar is actually helping Janet Yellen
Shark Tank Star's Brilliant Advice On Mortgage
Sponsored The Easy Loan Site
?
Dairy Queen CEO: What it's really like to work for Warren Buffett
Get ready for 'reverse quantitative easing'
John Kasich Reported to Suspend Presidential Campaign
If You Plan to Retire or Are Retired Read This Now
Sponsored Agora Financial
?
Are the Good Times Over for Tech Stocks?
European Stocks Register Fourth-Straight Decline
What Was Found In These Abandoned Airplanes Is...
Sponsored Definition
?
Vicente Fox on Trump, Corruption, and Mexico's Economy
Shell's BG Risk Pays Off in First-Quarter Profit Surprise
Rich GOP donors blow another $63 million
Trump Makes Another Enemy. Homeowners are Excited!
Sponsored TheEasyLoanSite.com
?
Trump is ‘unhinged’ but don't discount him: Rendell
There’s only one fundamental driving the markets right now
Bill Gross: 'Helicopter money' is coming in a year or so
See What A Billion Dollar Home Looks Like
Sponsored Housely.com
?
How a 13-year-old got connected with Warren Buffett and Rory McIlroy
U.S. factory orders rise solidly; inventories pick up
.
.
Copyright © 2016 <a href=http://www.marketwired.com/>Marketwire</a> L.P. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.
Data Disclaimer
Help / Suggestions
Privacy
About Our Ads
Terms
..
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.